Outcomes of Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Hypomethylating Agents With or Without Venetoclax: A Propensity Score-Adjusted Cohort Study

por Mustafa Ali, Moaath K., Corley, Elizabeth M., Alharthy, Hanan, Kline, Kathryn A. F., Law, Jennie Y., Lee, Seung Tae, Niyongere, Sandrine, Duong, Vu H., Emadi, Ashkan, Baer, Maria R.
Publicado 2022

Impact of IDH1 c.315C>T SNP on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort Study

por Corley, Elizabeth M., Mustafa Ali, Moaath K., Alharthy, Hanan, Kline, Kathryn A. F., Sewell, Danielle, Law, Jennie Y., Lee, Seung Tae, Niyongere, Sandrine, Duong, Vu H., Baer, Maria R., Emadi, Ashkan
Publicado 2022

Impact of FLT3-ITD Insertion Length on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort Study

por Corley, Elizabeth M., Mustafa Ali, Moaath K., Alharthy, Hanan, Kline, Kathryn A. F., Sewell, Danielle, Law, Jennie Y., Lee, Seung Tae, Niyongere, Sandrine, Duong, Vu H., Baer, Maria R., Emadi, Ashkan
Publicado 2022